187 related articles for article (PubMed ID: 8988341)
1. Bone mass homeostasis and bisphosphonate action.
Rodan GA
Bone; 1997 Jan; 20(1):1-4. PubMed ID: 8988341
[TBL] [Abstract][Full Text] [Related]
2. The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate--is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?
Delmas PD; Vergnaud P; Arlot ME; Pastoureau P; Meunier PJ; Nilssen MH
Bone; 1995 Jun; 16(6):603-10. PubMed ID: 7669436
[TBL] [Abstract][Full Text] [Related]
3. Tiludronate: bone pharmacology and safety.
Bonjour JP; Ammann P; Barbier A; Caverzasio J; Rizzoli R
Bone; 1995 Nov; 17(5 Suppl):473S-477S. PubMed ID: 8573421
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate therapy.
Licata AA
Am J Med Sci; 1997 Jan; 313(1):17-22. PubMed ID: 9001162
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients.
Jobke B; Milovanovic P; Amling M; Busse B
Bone; 2014 Feb; 59():37-43. PubMed ID: 24211427
[TBL] [Abstract][Full Text] [Related]
6. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
7. Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis.
McClung MR
Bone; 1996 Nov; 19(5 Suppl):195S-198S. PubMed ID: 8922662
[TBL] [Abstract][Full Text] [Related]
8. Issues in designing and testing a "cure" for osteoporosis.
Cummings S
J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):408. PubMed ID: 15758283
[No Abstract] [Full Text] [Related]
9. The potential role of bisphosphonates in prostate cancer.
Oades GM; Coxon J; Colston KW
Prostate Cancer Prostatic Dis; 2002; 5(4):264-72. PubMed ID: 12627210
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates use in children.
Sebestyen JF; Srivastava T; Alon US
Clin Pediatr (Phila); 2012 Nov; 51(11):1011-24. PubMed ID: 22935217
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of action of the bisphosphonates.
Fleisch H
Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of immobilization osteoporosis].
Inoue D
Nihon Rinsho; 2007 Nov; 65 Suppl 9():514-9. PubMed ID: 18159714
[No Abstract] [Full Text] [Related]
13. Stimulation of bone formation by dynamic mechanical loading of rat caudal vertebrae is not suppressed by 3-amino-1-hydroxypropylidene-1-bisphosphonate (AHPrBP).
Jagger CJ; Chambers TJ; Chow JW
Bone; 1995 Mar; 16(3):309-13. PubMed ID: 7786634
[TBL] [Abstract][Full Text] [Related]
14. [Bisphosphonates and combined treatments osteoporosis].
Rizzoli R; Ferrari S
Rev Med Suisse; 2005 Oct; 1(35):2266, 2269-71. PubMed ID: 16268449
[TBL] [Abstract][Full Text] [Related]
15. Clinical effects of bisphosphonates in involutional osteoporosis.
Ott SM
J Bone Miner Res; 1993 Dec; 8 Suppl 2():S597-606. PubMed ID: 8122531
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of bisphosphonate.].
Nakamura M; Koide M; Udagawa N
Clin Calcium; 2016; 26(11):1561-1570. PubMed ID: 27777389
[TBL] [Abstract][Full Text] [Related]
17. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
Seeman E
Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
[TBL] [Abstract][Full Text] [Related]
18. [Strontium ranelate: a novel concept for the treatment of osteoporosis].
Dimai HP
Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353
[TBL] [Abstract][Full Text] [Related]
19. Effects of tiludronate on bone loss in paraplegic patients.
Chappard D; Minaire P; Privat C; Berard E; Mendoza-Sarmiento J; Tournebise H; Basle MF; Audran M; Rebel A; Picot C
J Bone Miner Res; 1995 Jan; 10(1):112-8. PubMed ID: 7747617
[TBL] [Abstract][Full Text] [Related]
20. The role of bisphosphonates in the prevention and treatment of osteoporosis.
Papapoulos SE
Am J Med; 1993 Nov; 95(5A):48S-52S. PubMed ID: 8256796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
